DCTH Delcath Systems, Inc. - Common Stock
$17.21
가격 · 8월 19, 2026
기준 재무 정보 8월 6, 2026
52주 범위
$8–$17
98% of range
애널리스트 평점
BUY
12 analysts
목표 주가
$24
+39% upside
P/E (TTM)
245.9
ROE
2.5%
순이익률
3.2%
Delcath Systems, Inc. - Common Stock 정보 위키백과 회사 개요
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally.
더 보기
Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally (e.g. specialty drugs, melphalan (trade name Alkeran), busulfan, capecitabine).
## Phase III melanoma trial enrolling
University of Pittsburgh Medical Center
National Cancer Institute in Bethesda, Maryland
Albany Medical Center in Albany, New York
John Wayne Cancer Center in Santa Monica, California
Moffitt Cancer Center in Tampa, Florida
Morristown Memorial Hospital in Morristown, New Jersey
Providence Cancer Center in Portland, Oregon
St. Luke's Cancer Center of Bethlehem, Pennsylvania
Swedish Medical Center in Englewood, Colorado
University of Maryland Medical Center in Baltimore, Maryland
University of Texas Medical Branch in Galveston, Texas
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
DCTH 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$17.21
시가총액
$597M
P/E (TTM)
245.9
EPS (TTM)
$0.07
매출 (TTM)
$85M
배당 수익률
—
ROE
2.5%
부채/자본
—
52주 범위
$8 – $17
DCTH 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$85M
2016-12-31
→
2025-12-31
EPS
$0.07
2017-12-31
→
2025-12-31
잉여현금흐름
$21M
2018-12-31
→
2025-12-31
마진
3.2%
2022-12-31
→
2025-12-31
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
DCTH
동종업계 중앙값
P/E (TTM)
245.9
32.9
P/S (TTM)
7.0
4.6
P/B
5.4
3.5
Price / FCF (주가 / FCF)
28.5
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
DCTH
동종업계 중앙값
Gross Margin (매출 총이익률)
86.2%
66.5%
Operating Margin (영업이익률)
0.77%
—
Net Profit Margin (순이익률)
3.2%
-9.8%
ROA
2.7%
-8.8%
ROE
2.5%
-15.5%
ROIC
0.46%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
DCTH
동종업계 중앙값
Current Ratio (유동비율)
10.9
4.8
Quick Ratio (당좌 비율)
5.0
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
DCTH
동종업계 중앙값
Revenue YoY (매출 YoY)
129.1%
—
Revenue CAGR 3Y (매출 CAGR 3년)
215.3%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
DCTH
동종업계 중앙값
DCTH 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
12 명의 애널리스트
- 적극 매수 3 25.0%
- 매수 8 66.7%
- 보유 1 8.3%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
5 명의 애널리스트 · 2026-08-18
중앙값
$22.00
평균
$24.00
← 모든 목표가 하회
$17.21
저가
$21.00
고가
$32.00
중앙값 목표
$22.00
+27.8%
평균 목표
$24.00
+39.5%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.05%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $0.07 | $-0.09 | 0.16% |
| 2026년 3월 31일 | $-0.03 | $-0.09 | 0.06% |
| 2025년 12월 31일 | $-0.05 | $-0.06 | 0.01% |
| 2025년 9월 30일 | $0.02 | $0.02 | -0.00% |
| 2025년 6월 30일 | $0.07 | $0.03 | 0.04% |
| 2025년 3월 31일 | $0.03 | $0.02 | 0.01% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| SSII | — | -94.7 | 105.7% | — | — | — |
| ANGO | $479M | -13.0 | 9.5% | -11.5% | -21.2% | 54.6% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 18
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85M | $37M | $2M | $3M | $4M | · | · | · | $3M | $2M | $2M | $1M | |
| Cost of Revenue | $12M | $6M | $635.0K | $686.0K | $671.0K | $640.0K | $719.0K | $1M | $701.0K | $550.0K | $462.0K | $291.0K | |
| Gross Profit | $73M | $31M | $1M | $2M | $3M | $1M | $861.0K | $2M | $2M | $1M | $1M | $778.0K | |
| R&D Expense | $29M | $14M | $18M | $19M | $14M | $11M | $9M | $20M | $10M | $8M | $6M | $4M | |
| SG&A Expense | $44M | $30M | $22M | $17M | $14M | $11M | $11M | $10M | $10M | $9M | $10M | $16M | |
| Operating Expenses | $73M | $43M | $40M | $36M | $27M | $22M | $21M | $29M | $20M | $18M | $16M | $20M | |
| Operating Income | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | $-18M | $-16M | $-15M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | · | $22M | $14M | $67.0K | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $17.0K | $9.0K | $5.0K | |
| Other Non-op | $-70.0K | $-30.0K | $-59.0K | $30.0K | $68.0K | $154.0K | $2.0K | $51.0K | $-41.0K | $17.0K | $9.0K | $-24.0K | |
| Pretax Income | $4M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Income Tax | $810.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| EPS (Basic) | $0.08 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| EPS (Diluted) | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| Shares (Basic) | 35,821,157 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| Shares (Diluted) | 39,919,557 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| EBITDA | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | · | · | $-15M | $-19M |
대차대조표 25
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $32M | $13M | $8M | $23M | $29M | $10M | $3M | $4M | $4M | $13M | $20M | |
| Receivables | $12M | $11M | $241.0K | $366.0K | $44.0K | $57.0K | $21.0K | $585.0K | $317.0K | $403.0K | $277.0K | $174.0K | |
| Inventory | $10M | $7M | $3M | $2M | $1M | $855.0K | $654.0K | $858.0K | $1M | $660.0K | $757.0K | $349.0K | |
| Prepaid Expense | $6M | $3M | $1M | $2M | $3M | $3M | $2M | $898.0K | $700.0K | $698.0K | $960.0K | $974.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $222.0K | |
| Current Assets | $120M | $74M | $37M | $16M | $31M | $32M | $13M | $6M | $8M | $34M | $15M | $22M | |
| PP&E (Net) | $3M | $2M | $1M | $1M | $1M | $1M | $735.0K | $925.0K | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Total Assets | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Accounts Payable | $3M | $961.0K | $1M | $2M | $638.0K | $2M | $5M | $8M | $4M | $594.0K | $284.0K | $748.0K | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | $3M | $3M | $2M | $4M | |
| Current Liabilities | $11M | $6M | $16M | $15M | $6M | $10M | $16M | $18M | $8M | $36M | $6M | $5M | |
| Capital Leases | $835.0K | $933.0K | $0 | · | $207.0K | $450.0K | $197.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | $628.0K | $766.0K | $840.0K | $1M | $207.0K | · | $0 | $628.0K | $395.0K | $604.0K | $820.0K | $1M | |
| Total Liabilities | $12M | $8M | $23M | $24M | $21M | $13M | $21M | $22M | $8M | $37M | $7M | $6M | |
| Long-term Debt | · | $0 | $10M | $16M | · | · | · | · | · | · | · | · | |
| Common Stock | $347.0K | $331.0K | $228.0K | $100.0K | $79.0K | $60.0K | $1.0K | $0 | $2.0K | $0 | $14.0K | $97.0K | |
| Paid-in Capital | $639M | $600M | $521M | $452M | $433M | $417M | $365M | $329M | $326M | $278M | $270M | $265M | |
| Retained Earnings | $-529M | $-532M | $-505M | $-457M | $-421M | $-395M | $-371M | $-344M | $-325M | $-279M | $-261M | $-247M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $51.0K | $51.0K | $51.0K | $51.0K | |
| AOCI | $575.0K | $82.0K | $135.0K | $-83.0K | $18.0K | $-104.0K | $28.0K | $50.0K | $42.0K | $-41.0K | $-8.0K | $20.0K | |
| Stockholders' Equity | $111M | $69M | $16M | $-6M | $12M | $22M | $-6M | $-15M | $678.0K | $-1M | $9M | $18M | |
| Liabilities + Equity | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Shares Outstanding | 34,691,671 | 33,061,002 | 22,761,554 | 10,046,571 | 7,906,728 | 5,996,101 | 67,091 | 14,715 | 228,139 | 11,750 | 1,360,239 | 9,708,841 |
현금 흐름 12
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $23M | $-19M | $-31M | $-25M | $-23M | $-23M | $-24M | $-15M | $-15M | $-14M | $-16M | $-16M | |
| CapEx | $2M | $559.0K | $58.0K | $209.0K | $143.0K | $782.0K | $24.0K | $76.0K | $524.0K | $258.0K | $170.0K | $44.0K | |
| Investing Cash Flow | $-27M | $-981.0K | $-20M | $-209.0K | $-143.0K | $-782.0K | $-24.0K | $-76.0K | $-524.0K | · | · | · | |
| Net Debt Issued | · | $-11M | $-6M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $481.0K | $250.0K | $123.0K | $0 | $2M | $230.0K | $0 | $11M | · | · | · | · | |
| Stock Repurchased | $6M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-6M | $250.0K | $123.0K | · | $2M | $230.0K | $0 | · | · | · | · | · | |
| Financing Cash Flow | $15M | $39M | $52M | $10M | $21M | $42M | $30M | $13M | $-11M | · | · | · | |
| Net Change in Cash | $11M | $20M | $874.0K | $-15M | $-2M | $19M | $7M | $-2M | $-26M | $-8M | $-8M | $-11M | |
| Taxes Paid | $2M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $21M | $-19M | $-31M | $-25M | $-23M | $-24M | $-24M | $-15M | · | · | $-17M | $-16M |
수익성 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.2% | 83.4% | 69.2% | 74.8% | · | · | · | · | · | · | 73.6% | 72.8% | |
| Operating Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| Net Margin | 3.2% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | -1625.9% | |
| Pretax Margin | 4.1% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | · | |
| EBITDA Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| ROA | 2.7% | -45.8% | -168.8% | -143.2% | -75.7% | -98.9% | -84.3% | -244.4% | · | · | -74.5% | -57.1% | |
| ROE | 2.5% | -68.2% | -235.5% | 657.5% | -216.7% | -190.6% | 70.5% | 194.1% | · | · | -109.9% | -72.0% | |
| ROIC | 0.46% | -18.1% | -242.0% | 577.8% | -205.3% | -96.5% | 313.2% | · | · | · | -176.8% | · |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 | 3.2 | 0.8 | 0.3 | · | · | 2.3 | 4.8 | |
| Quick Ratio | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 | 2.9 | 0.6 | 0.2 | · | · | 2.0 | 4.5 |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.6 | 0.1 | 0.1 | · | · | · | · | · | · | 0.1 | 0.0 | |
| Inventory Turnover | 1.4 | 1.2 | 0.2 | 0.4 | 0.6 | 0.8 | 1.0 | 1.0 | · | · | 0.8 | 0.5 | |
| Receivables Turnover | 7.5 | 6.7 | 6.8 | 13.3 | · | · | · | · | · | · | 7.7 | 4.1 |
성장률 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 129.1% | 1701.7% | -24.1% | -23.5% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 215.3% | 118.7% | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $85M | $37M | $2M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Net Income TTM | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Market Cap | $350M | $398M | $95M | $28M | $61M | $107M | $1M | $2.01B | · | · | · | · | |
| P/E | 144.3 | -12.9 | -1.4 | -0.9 | -2.2 | -2.1 | -0.1 | -272.2 | · | · | · | · | |
| P/S | 4.1 | 10.7 | 45.9 | 10.5 | 17.2 | 34.8 | 0.5 | 649.3 | · | · | · | · | |
| P/B | 3.2 | 5.8 | 6.0 | -4.9 | 5.1 | 4.9 | -0.2 | -134.2 | · | · | · | · | |
| P / Tangible Book | 3.2 | 5.8 | 6.0 | · | 5.1 | 4.9 | · | · | · | · | · | · | |
| P / Cash Flow | 15.6 | -21.3 | -3.0 | -1.1 | -2.7 | -4.7 | -0.1 | -136.1 | · | · | · | · | |
| P / FCF | 16.7 | -20.7 | -3.0 | -1.1 | -2.7 | -4.5 | -0.1 | -135.4 | · | · | · | · | |
| Earnings Yield | 0.69% | -7.7% | -70.7% | -114.4% | -46.3% | -46.6% | -1613.3% | -0.37% | · | · | · | · |
손익계산서 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $25M | $21M | $21M | $24M | $20M | $15M | $11M | $8M | $3M | $539.0K | $434.0K | $495.0K | $597.0K | $638.0K | $906.0K | |
| Cost of Revenue | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $903.0K | $171.0K | $133.0K | $150.0K | $181.0K | $238.0K | $235.0K | |
| Gross Profit | $26M | $21M | $18M | $18M | $21M | $17M | $13M | $10M | $6M | $2M | $368.0K | $301.0K | $345.0K | $416.0K | $400.0K | $671.0K | |
| R&D Expense | $10M | $10M | $9M | $8M | $7M | $5M | $3M | $4M | $3M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | |
| SG&A Expense | $13M | $13M | $11M | $10M | $11M | $11M | $7M | $7M | $7M | $9M | $7M | $6M | $5M | $4M | $4M | $5M | |
| Operating Expenses | $24M | $23M | $20M | $18M | $18M | $16M | $10M | $11M | $10M | $13M | $12M | $11M | $8M | $9M | $8M | $9M | |
| Operating Income | $2M | $-2M | $-2M | $-388.0K | $3M | $642.0K | $3M | $-1M | $-4M | $-10M | $-11M | $-11M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $-17.0K | $-58.0K | $-7.0K | $-33.0K | $-34.0K | $4.0K | $-53.0K | $35.0K | $10.0K | $-22.0K | $-73.0K | $-5.0K | $6.0K | $13.0K | $27.0K | $26.0K | |
| Pretax Income | $3M | $-908.0K | $-1M | $375.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | · | · | · | · | · | · | |
| Income Tax | $491.0K | $162.0K | $562.0K | $-455.0K | $508.0K | $195.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $3M | $-1M | $-2M | $830.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | $-11M | $-20M | $-7M | $-9M | $-8M | $-9M | |
| EPS (Basic) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.08 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| EPS (Diluted) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.07 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| Shares (Basic) | 35,891,915 | 36,021,210 | -70,991,574 | 36,383,277 | 35,786,813 | 34,642,641 | -53,478,825 | 28,738,307 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| Shares (Diluted) | 39,761,480 | 36,021,210 | -79,911,141 | 40,056,814 | 40,262,764 | 39,511,120 | -57,086,190 | 32,345,672 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| EBITDA | $2M | $-2M | · | $-388.0K | $3M | $642.0K | · | $-1M | $-4M | $-10M | · | $-11M | $-8M | $-8M | · | $-8M |
대차대조표 23
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $41M | $43M | $42M | $34M | $13M | $32M | $8M | $15M | $12M | $13M | $40M | $15M | $24M | $8M | $10M | |
| Receivables | $16M | $14M | $12M | $14M | $16M | $14M | $11M | $7M | $4M | $2M | $241.0K | $205.0K | $127.0K | $458.0K | $366.0K | $537.0K | |
| Inventory | $12M | $10M | $10M | $11M | $11M | $7M | $7M | $7M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $7M | $7M | $6M | $7M | $6M | $4M | $3M | $1M | $1M | $1M | $1M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $131M | $120M | $120M | $121M | $113M | $84M | $74M | $29M | $31M | $34M | $37M | $46M | $19M | $29M | $16M | $18M | |
| PP&E (Net) | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Assets | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Accounts Payable | $4M | $3M | $3M | $2M | $5M | $2M | $961.0K | $937.0K | $3M | $1M | $1M | $753.0K | $966.0K | $2M | $2M | $3M | |
| Accrued Liabilities | $9M | $7M | $8M | $6M | $6M | $4M | $5M | $6M | $4M | $4M | $5M | $5M | $6M | $7M | $5M | $5M | |
| Current Liabilities | $13M | $11M | $11M | $8M | $10M | $5M | $6M | $22M | $12M | $13M | $16M | $14M | $11M | $13M | $15M | $14M | |
| Capital Leases | $2M | $815.0K | $835.0K | $855.0K | $877.0K | $906.0K | $933.0K | $963.0K | $989.0K | $1M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | $327.0K | $615.0K | $628.0K | $582.0K | $578.0K | $896.0K | $766.0K | $563.0K | $632.0K | $962.0K | $840.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $16M | $12M | $12M | $9M | $12M | $7M | $8M | $23M | $30M | $21M | $23M | $23M | $21M | $25M | $24M | $25M | |
| Long-term Debt | · | · | · | · | · | · | · | $2M | $4M | $7M | $10M | · | · | · | $16M | · | |
| Common Stock | $346.0K | $344.0K | $347.0K | $353.0K | $350.0K | $334.0K | $331.0K | $280.0K | $279.0K | $254.0K | $228.0K | $197.0K | $153.0K | $101.0K | $100.0K | $86.0K | |
| Paid-in Capital | $648M | $642M | $639M | $641M | $632M | $610M | $600M | $536M | $534M | $530M | $521M | $519M | $473M | $453M | $452M | $442M | |
| Retained Earnings | $-527M | $-530M | $-529M | $-527M | $-528M | $-530M | $-532M | $-528M | $-530M | $-516M | $-505M | $-494M | $-474M | $-466M | $-457M | $-447M | |
| AOCI | $258.0K | $571.0K | $575.0K | $875.0K | $592.0K | $381.0K | $82.0K | $11.0K | $8.0K | $157.0K | $135.0K | $-59.0K | $-64.0K | $-64.0K | $-83.0K | $-57.0K | |
| Stockholders' Equity | $121M | $113M | $111M | $115M | $105M | $80M | $69M | $9M | $4M | $15M | $16M | $25M | $-242.0K | $-13M | $-6M | $-5M | |
| Liabilities + Equity | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Shares Outstanding | 34,636,252 | 34,465,087 | 34,691,671 | 35,308,939 | 34,955,974 | 33,436,612 | 33,061,002 | 28,019,599 | 27,931,393 | 25,439,319 | 22,761,554 | 19,688,991 | 15,250,469 | 10,046,571 | 10,046,571 | 8,597,682 |
현금 흐름 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6M | $857.0K | $8M | $5M | $7M | $2M | $-1M | $-4M | $-4M | $-10M | $-8M | $-9M | $-10M | $-4M | $-7M | $-5M | |
| CapEx | $503.0K | $570.0K | $550.0K | $459.0K | $398.0K | $140.0K | $229.0K | $216.0K | $101.0K | $13.0K | $19.0K | $-1.0K | $40.0K | $0 | $0 | $68.0K | |
| Investing Cash Flow | $-504.0K | $-571.0K | $-561.0K | $-466.0K | $-415.0K | $-25M | $-15M | $-697.0K | $10M | $5M | $-20M | $1.0K | $-40.0K | $0 | $0 | $-68.0K | |
| Stock Issued | $0 | $389.0K | $0 | $243.0K | $0 | $238.0K | $0 | $175.0K | $0 | $75.0K | $0 | $76.0K | $0 | $47.0K | $0 | $0 | |
| Stock Repurchased | $11.0K | $3M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-3M | · | · | · | $238.0K | · | · | · | $75.0K | · | · | · | $47.0K | · | · | |
| Financing Cash Flow | $962.0K | $-2M | $-6M | $3M | $15M | $3M | $40M | $-2M | $-3M | $4M | $1.0K | $35M | $7.0K | $17M | $5M | $5M | |
| Net Change in Cash | $6M | $-2M | $2M | $7M | $22M | $-20M | $24M | $-6M | $3M | $-886.0K | $-28M | $26M | $-10M | $12M | $-2M | $-372.0K | |
| Taxes Paid | · | · | $228.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $287.0K | · | · | · | $2M | · | · | · | $-10M | · | · | · | $-4M | · | · |
수익성 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.8% | 85.0% | · | 87.2% | 86.3% | 85.6% | · | 85.4% | 80.4% | 71.2% | · | 69.3% | 69.7% | 69.7% | · | · | |
| Operating Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| Net Margin | 9.2% | -4.3% | · | 4.0% | 11.2% | 5.4% | · | 16.6% | -176.9% | -354.0% | · | -4686.6% | -1455.0% | -1507.5% | · | · | |
| Pretax Margin | 10.8% | -3.6% | · | 1.8% | 13.3% | 6.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| ROA | 2.1% | -1.0% | · | 1.1% | 3.6% | 1.7% | · | 4.7% | -50.0% | -33.3% | · | -60.0% | -34.2% | -31.1% | · | -31.1% | |
| ROE | 2.4% | -1.1% | · | 1.4% | 4.9% | 2.2% | · | 11.2% | -695.8% | -1439.2% | · | -208.9% | 466.5% | 229.3% | · | -262.5% | |
| ROIC | 1.7% | -1.7% | · | -0.75% | 2.1% | 0.68% | · | · | · | · | · | · | · | · | · | · |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.8 | 11.2 | · | 15.1 | 10.9 | 16.0 | · | 1.3 | 2.6 | 2.5 | · | 3.3 | 1.8 | 2.2 | · | 1.3 | |
| Quick Ratio | 4.8 | 5.2 | · | 6.9 | 4.8 | 5.1 | · | 0.7 | 1.5 | 1.0 | · | 2.9 | 1.3 | 1.8 | · | 0.7 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.8 | 1.8 | · | 2.0 | 2.5 | 2.6 | · | 3.1 | 4.0 | 3.1 | · | 1.2 | 1.8 | 1.9 | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $99M | $89M | · | $76M | $63M | $42M | · | $23M | $12M | $5M | · | $2M | $3M | $3M | · | · | |
| Net Income TTM | $5M | $4M | · | $6M | $-8M | $-22M | · | $-43M | $-52M | $-48M | · | $-45M | $-35M | $-37M | · | $-35M | |
| Market Cap | $436M | $320M | · | $380M | $475M | $426M | · | $253M | $234M | $121M | · | $80M | $89M | $58M | · | $28M | |
| P/E | 96.8 | 103.1 | · | 59.7 | -42.5 | -15.2 | · | -4.5 | -3.2 | -1.6 | · | -1.2 | -1.6 | -1.4 | · | -0.8 | |
| P/S | 4.4 | 3.6 | · | 5.0 | 7.6 | 10.2 | · | 11.2 | 19.8 | 26.0 | · | 32.8 | 31.8 | 21.6 | · | · | |
| P/B | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | -367.4 | -4.4 | · | -5.2 | |
| P / Tangible Book | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | · | · | · | · | |
| P / Cash Flow | · | 373.2 | · | · | · | 193.2 | · | · | · | -12.7 | · | · | · | -13.5 | · | · | |
| P / FCF | · | 1114.4 | · | · | · | 206.3 | · | · | · | -12.6 | · | · | · | -13.5 | · | · | |
| Earnings Yield | 1.0% | 0.97% | · | 1.7% | -2.4% | -6.6% | · | -22.3% | -31.7% | -61.6% | · | -85.2% | -60.9% | -70.8% | · | -132.5% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $85M | $37M | $2M | $3M | $4M |
| 매출 총이익률 % | 86.2% | 83.4% | 69.2% | 74.8% | — |
| 영업이익률 % | 0.77% | -33.4% | -1849.0% | -1245.0% | — |
| 순이익 | $3M | $-26M | $-48M | $-37M | $-26M |
| 희석 EPS | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 |
| 당좌 비율 | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $21M | $-19M | $-31M | $-25M | $-23M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 140개의 제출자 · $188.2M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 27 (0 이전 분기 대비) | 17 (-3 이전 분기 대비) | 40 (+6 이전 분기 대비) | 30 (-7 이전 분기 대비) | +1.7M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $41,551,898 | 3,300,389 | 22.08% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $15,375,500 | 1,221,247 | 8.17% | 주식 |
| VANGUARD GROUP INC | $14,879,573 | 1,473,225 | 7.91% | 주식 |
| Propel Bio Management, LLC | $10,971,681 | 871,460 | 5.83% | 주식 |
| STATE STREET CORP | $8,552,135 | 679,280 | 4.55% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $7,923,535 | 629,139 | 4.21% | 주식 |
| ALGERT GLOBAL LLC | $7,311,114 | 580,708 | 3.89% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $7,130,611 | 566,371 | 3.79% | 주식 |
| Divisadero Street Capital Management, LP | $6,292,432 | 499,796 | 3.34% | 주식 |
| ExodusPoint Capital Management, LP | $4,530,940 | 359,884 | 2.41% | 주식 |
| Private Wealth Advisors, LLC | $3,913,765 | 310,863 | 2.08% | 주식 |
| Simplify Asset Management Inc. | $3,333,454 | 264,770 | 1.77% | 주식 |
| BlackRock, Inc. | $3,180,738 | 252,640 | 1.69% | 주식 |
| ADAR1 Capital Management, LLC | $2,825,007 | 224,385 | 1.50% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $2,570,450 | 204,166 | 1.37% | 주식 |
| KENNEDY CAPITAL MANAGEMENT LLC | $2,570,160 | 204,143 | 1.37% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,435,510 | 193,448 | 1.29% | 주식 |
| Ikarian Capital, LLC | $2,337,548 | 185,667 | 1.24% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $2,290,159 | 181,903 | 1.22% | 주식 |
| CIBC WORLD MARKET INC. | $2,054,789 | 163,208 | 1.09% | 주식 |
| Caption Management, LLC | $1,894,795 | 150,500 | 1.01% | 풋 옵션 |
| GOLDMAN SACHS GROUP INC | $1,885,353 | 149,750 | 1.00% | 주식 |
| Lane Generational LLC | $1,884,257 | 149,663 | 1.00% | 주식 |
| HSBC HOLDINGS PLC | $1,705,848 | 135,600 | 0.91% | 주식 |
| Man Group plc | $1,617,752 | 128,495 | 0.86% | 주식 |
| Cubist Systematic Strategies, LLC | $1,562,514 | 145,350 | 0.83% | 주식 |
| Diametric Capital, LP | $1,546,568 | 122,841 | 0.82% | 주식 |
| MORGAN STANLEY | $1,366,506 | 108,539 | 0.73% | 주식 |
| BARCLAYS PLC | $1,354,243 | 107,565 | 0.72% | 주식 |
| Caption Management, LLC | $1,259,000 | 100,000 | 0.67% | 콜 옵션 |
| Capital Advisors Wealth Management, LLC | $1,170,870 | 93,000 | 0.62% | 주식 |
| Jefferies Financial Group Inc. | $1,057,308 | 83,980 | 0.56% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,050,824 | 83,465 | 0.56% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,022,308 | 81,200 | 0.54% | 콜 옵션 |
| Stonepine Capital Management, LLC | $1,000,000 | 100,000 | 0.53% | 콜 옵션 |
| Caption Management, LLC | $978,243 | 77,700 | 0.52% | 주식 |
| FOX RUN MANAGEMENT, L.L.C. | $776,526 | 61,678 | 0.41% | 주식 |
| Quantbot Technologies LP | $749,860 | 59,560 | 0.40% | 주식 |
| D. E. Shaw & Co., Inc. | $728,885 | 57,894 | 0.39% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $725,864 | 57,654 | 0.39% | 주식 |
| Pale Fire Capital SE | $504,670 | 40,085 | 0.27% | 주식 |
| BANK OF AMERICA CORP /DE/ | $493,931 | 39,232 | 0.26% | 주식 |
| WOLVERINE TRADING, LLC | $479,600 | 44,000 | 0.25% | 콜 옵션 |
| RHUMBLINE ADVISERS | $458,822 | 36,444 | 0.24% | 주식 |
| ALPS ADVISORS INC | $441,154 | 35,040 | 0.23% | 주식 |
| EntryPoint Capital, LLC | $437,641 | 34,761 | 0.23% | 주식 |
| SEI INVESTMENTS CO | $394,936 | 31,369 | 0.21% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $378,380 | 30,054 | 0.20% | 주식 |
| Balyasny Asset Management L.P. | $358,412 | 28,468 | 0.19% | 주식 |
| Leonteq Securities AG | $348,730 | 27,699 | 0.19% | 주식 |
| CITADEL ADVISORS LLC | $334,894 | 26,600 | 0.18% | 콜 옵션 |
| BOOTHBAY FUND MANAGEMENT, LLC | $319,484 | 25,376 | 0.17% | 주식 |
| Xcelsior Advisor Partners LLC | $318,527 | 25,300 | 0.17% | 주식 |
| Palisades Investment Partners, LLC | $293,007 | 23,273 | 0.16% | 주식 |
| WOLVERINE TRADING, LLC | $269,666 | 24,740 | 0.14% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $239,424 | 25,800 | 0.13% | 주식 |
| MetLife Investment Management, LLC | $235,043 | 18,669 | 0.12% | 주식 |
| Bank of New York Mellon Corp | $234,942 | 18,661 | 0.12% | 주식 |
| WealthPlan Investment Management, LLC | $219,607 | 17,443 | 0.12% | 주식 |
| NOMURA HOLDINGS INC | $210,530 | 16,722 | 0.11% | 주식 |
| WOLVERINE TRADING, LLC | $209,280 | 19,200 | 0.11% | 풋 옵션 |
| CITADEL ADVISORS LLC | $202,699 | 16,100 | 0.11% | 풋 옵션 |
| CITADEL ADVISORS LLC | $189,391 | 15,043 | 0.10% | 주식 |
| SkyOak Wealth, LLC | $188,850 | 15,000 | 0.10% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $188,850 | 15,000 | 0.10% | 풋 옵션 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $166,729 | 13,243 | 0.09% | 주식 |
| TUDOR INVESTMENT CORP ET AL | $151,609 | 12,042 | 0.08% | 주식 |
| LANARK FINANCIAL, INC. | $150,500 | 11,954 | 0.08% | 주식 |
| CITIGROUP INC | $146,485 | 11,635 | 0.08% | 주식 |
| Invesco Ltd. | $143,790 | 11,421 | 0.08% | 주식 |
| MERCER GLOBAL ADVISORS INC /ADV | $140,744 | 11,179 | 0.07% | 주식 |
| Nuveen, LLC | $138,754 | 11,021 | 0.07% | 주식 |
| Vanguard Global Advisers, LLC | $133,869 | 10,633 | 0.07% | 주식 |
| Schonfeld Strategic Advisors LLC | $131,136 | 10,416 | 0.07% | 주식 |
| LPL Financial LLC | $128,859 | 10,235 | 0.07% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $126,580 | 10,054 | 0.07% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $110,729 | 8,795 | 0.06% | 주식 |
| SHERBROOKE PARK ADVISERS LLC | $109,918 | 10,883 | 0.06% | 주식 |
| Hunting Hill Global Capital, LLC | $104,716 | 11,284 | 0.06% | 주식 |
| MARSHALL WACE, LLP | $84,177 | 6,686 | 0.04% | 주식 |
| FMR LLC | $69,144 | 5,492 | 0.04% | 주식 |
| Private Wealth Advisors, LLC | $62,950 | 5,000 | 0.03% | 콜 옵션 |
| NEW YORK STATE COMMON RETIREMENT FUND | $60,432 | 4,800 | 0.03% | 주식 |
| OSAIC HOLDINGS, INC. | $60,254 | 4,786 | 0.03% | 주식 |
| Point72 (DIFC) Ltd | $53,931 | 5,017 | 0.03% | 주식 |
| NORTHERN TRUST CORP | $53,797 | 4,273 | 0.03% | 주식 |
| Persistent Asset Partners Ltd | $52,954 | 4,206 | 0.03% | 주식 |
| Arax Advisory Partners | $51,884 | 4,121 | 0.03% | 주식 |
| IFP Advisors, Inc | $51,657 | 4,103 | 0.03% | 주식 |
| Integrated Wealth Concepts LLC | $48,145 | 3,824 | 0.03% | 주식 |
| Ameritas Investment Partners, Inc. | $38,714 | 3,075 | 0.02% | 주식 |
| Legal & General Group Plc | $34,534 | 2,743 | 0.02% | 주식 |
| CWM, LLC | $29,343 | 3,162 | 0.02% | 주식 |
| Creative Planning | $17,777 | 1,412 | 0.01% | 주식 |
| Tripletail Wealth Management, LLC | $16,632 | 1,260 | 0.01% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14,950 | 1,611 | 0.01% | 주식 |
| AlphaQuest LLC | $14,473 | 1,433 | 0.01% | 주식 |
| Tower Research Capital LLC (TRC) | $13,711 | 1,089 | 0.01% | 주식 |
| Activest Wealth Management | $12,590 | 1,000 | 0.01% | 주식 |
| Geneos Wealth Management Inc. | $11,621 | 923 | 0.01% | 주식 |
회사 내부자 46 명의 내부자 · 11 임원 · 16 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Jennifer K. Simpson | President and CEO | 2020년 5월 8일 C | 25,021 | 0 | 0 | $0 |
| Barbra Keck | Chief Financial Officer, Secretary | 2020년 5월 8일 C | 12,851 | 0 | 0 | $0 |
| Paul M Feinstein | Chief Financial Officer | 2007년 11월 30일 A | 3,375 | 0 | 0 | $0 |
| John Purpura | Chief Operating Officer | 2023년 10월 13일 P | 41,526 | 0 | 0 | $0 |
| HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 2007년 5월 29일 P | 160,375 | 0 | 0 | $0 |
| Vojo Vukovic | Chief Medical Officer | 2023년 12월 12일 P | 100,000 | 0 | 0 | $0 |
| Sandra Pennell | SVP of Finance, PFO and PAO | 2023년 11월 17일 P | 30,000 | 0 | 0 | $0 |
| David L. Hoffman | General Counsel, Chief Compliance Officer and Secretary | 2023년 11월 16일 P | 40,000 | 0 | 0 | $0 |
| Kevin Muir | Vice President Commercial Operations | 2023년 6월 12일 A | — | 0 | 0 | $0 |
| Johnny John | Senior Vice President Clinical Development and Medical Affairs | 2023년 6월 12일 A | — | 0 | 0 | $0 |
| Christine Padula | Interim Principal Accounting Officer | 2021년 9월 1일 A | — | 0 | 0 | $0 |
| John Richard Sylvester | 이사 | 2023년 8월 21일 P | 10,550 | 0 | 0 | $0 |
| Aharon Gil | 이사 | 2023년 6월 12일 A | 404,000 | 0 | 0 | $0 |
| Steven A J Salamon | 이사 | 2023년 6월 12일 A | 440,100 | 0 | 0 | $0 |
| Roger G Stoll PHD | 이사 | 2023년 6월 12일 A | 9,309 | 0 | 0 | $0 |
| Rosalind Advisors, Inc. | 이사 | 2022년 4월 19일 P | 433,100 | 0 | 0 | $0 |
| Marco Taglietti | 이사 | 2020년 5월 8일 C | 6,000 | 0 | 0 | $0 |
| William Dodge Rueckert | 이사 | 2020년 5월 8일 C | 6,014 | 0 | 0 | $0 |
| Simon Pedder | 이사 | 2019년 2월 1일 A | — | 0 | 0 | $0 |
| Laura A Philips | 이사 | 2015년 7월 23일 P | 205,299 | 0 | 0 | $0 |
| Harold S Koplewicz | 이사 | 2015년 6월 10일 A | 45,052 | 0 | 0 | $0 |
| Dennis Langer | 이사 | 2015년 6월 10일 A | 20,000 | 0 | 0 | $0 |
| Jonathan Lewis | 이사 | 2008년 6월 30일 A | 10,000 | 0 | 0 | $0 |
| Mark Corigliano | 이사 | 2007년 4월 16일 M | 198,176 | 0 | 0 | $0 |
| Daniel Isdaner | 이사 | 2007년 4월 16일 M | 253,668 | 0 | 0 | $0 |
| Elizabeth Czerepak | — | 2026년 5월 13일 A | — | 0 | 0 | $0 |
| Gerard J Michel | — | 2026년 3월 2일 P | 342,034 | 2 | 0 | $198,447 |
| Laura Brege | — | 2014년 7월 7일 A | 11,678 | 0 | 0 | $0 |
| Tasos Konidaris | — | 2014년 7월 7일 A | 11,678 | 0 | 0 | $0 |
| Gabriel Leung | — | 2014년 7월 7일 A | 21,485 | 0 | 0 | $0 |
| Douglas G Watson | — | 2014년 7월 7일 A | 136,664 | 0 | 0 | $0 |
| Graham G Miao | — | 2013년 11월 14일 A | 54,000 | 0 | 0 | $0 |
| Peter J Graham | — | 2013년 11월 14일 A | 15,000 | 0 | 0 | $0 |
| William M Appling | — | 2013년 7월 15일 A | — | 0 | 0 | $0 |
| Krishna Kandarpa | — | 2013년 3월 11일 A | 159,000 | 0 | 0 | $0 |
| Harold Mapes | — | 2013년 3월 11일 A | 17,000 | 0 | 0 | $0 |
| Eamonn P Hobbs | — | 2013년 3월 11일 A | 162,000 | 0 | 0 | $0 |
| Agustin V Gago | — | 2013년 3월 11일 A | 80,944 | 0 | 0 | $0 |
| Robert Ladd | — | 2012년 6월 15일 A | 69,534 | 0 | 0 | $0 |
| David Mcdonald | — | 2011년 3월 10일 A | 47,706 | 0 | 0 | $0 |
| Pamela Reilly Contag | — | 2010년 12월 1일 A | 8,507 | 0 | 0 | $0 |
| Richard Taney | — | 2009년 12월 10일 A | 211,485 | 0 | 0 | $0 |
| Jason Andrew Rifkin | — | 2009년 10월 12일 A | — | 0 | 0 | $0 |
| KOLY M S /FA/ | — | 2007년 1월 26일 X | 775,360 | 0 | 0 | $0 |
| Victor Nevins | — | 2006년 10월 12일 M | 180,007 | 0 | 0 | $0 |
| VENKOL TRUST | — | 2004년 11월 10일 J | 892,649 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 17 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc., SALAMON STEVEN A J, Aharon Gil, Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P. ×15 제출 서류 | 2026년 2월 10일 | 9.90% | 수정본 | — | SEC |
| 미공개 보고자 | 2022년 12월 16일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2022년 7월 27일 | — | 최초 제출 | — | SEC |
| Laddcap Value Partners LP S.S. or, Laddcap Value Associates LLC S.S. or, Laddcap Value Advisors LLC S.S. or, Robert Ladd S.S. or ×2 제출 서류 | 2010년 8월 2일 | — | 최초 제출 | — | SEC |
| Robert Ladd | 2006년 10월 18일 | — | 최초 제출 | 수동적 투자 | SEC |
| 미공개 보고자 | 2006년 7월 28일 | — | 최초 제출 | 이사회 캠페인 | SEC |
| 미공개 보고자 | 2006년 7월 11일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2006년 6월 14일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2006년 6월 8일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2006년 5월 24일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2006년 4월 28일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2006년 1월 10일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2006년 1월 6일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2005년 12월 14일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2005년 11월 10일 | — | 최초 제출 | 이사회 캠페인 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 22 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0.24% | 35,814 NS | 2026년 5월 31일 | N-PORT |
| IWC · iShares Trust | 0.10% | 97,850 SH | 2026년 8월 8일 | 일간 |
| GSSC · Goldman Sachs ETF Trust | 0.04% | 35,321 NS | 2026년 5월 31일 | N-PORT |
| IWN · iShares Trust | 0.02% | 227,534 SH | 2026년 8월 8일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 21,358 SH | 2026년 8월 8일 | 일간 |
| IWM · iShares Trust | 0.01% | 741,852 SH | 2026년 8월 8일 | 일간 |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.01% | 2,388 SH | 2026년 8월 8일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 165,177 SH | 2026년 8월 8일 | 일간 |
| RSSL · Global X Funds | 0.01% | 13,080 NS | 2026년 4월 30일 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 22,609 NS | 2026년 5월 31일 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 1,420 NS | 2026년 5월 31일 | N-PORT |
| UWM · ProShares Trust | 0.00% | 1,111 NS | 2026년 5월 31일 | N-PORT |
| IWO · iShares Trust | 0.00% | 38,572 SH | 2026년 8월 8일 | 일간 |
| URTY · ProShares Trust | 0.00% | 1,122 NS | 2026년 5월 31일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,638 NS | 2026년 5월 31일 | N-PORT |
| HDG · ProShares Trust | 0.00% | 28 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 19,222 NS | 2026년 4월 30일 | N-PORT |
| ITOT · iShares Trust | 0.00% | 43,750 SH | 2026년 8월 8일 | 일간 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 304,809 SH | 2026년 8월 8일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 889,410 SH | 2026년 8월 8일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 4,438 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,475 SH | 2026년 8월 8일 | 일간 |